Biocryst Pharmaceuticals Inc (BCRX)

02:12 AM

BioCryst Pharmaceuticals (NASDAQ:BCRX) Trading Up 6%Here's What Happened - MarketBeat

02:12 AM

07:49 AM

BioCryst names Sandeep Menon as chief R&D officer By Investing.com - Investing.com Canada

07:49 AM

07:12 AM

BioCryst Pharmaceuticals Appoints Dr. Sandeep M. Menon as Chief Research and Development Officer - Quiver Quantitative

07:12 AM

07:01 AM

BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer - marketscreener.com

07:01 AM

07:00 AM

BioCryst taps AMVUTTRA, PAXLOVID veteran to lead R&D effort - Stock Titan

07:00 AM

05:23 AM

BioCryst (BCRX) rallies 7.10% on acquisition buzz - MSN

05:23 AM

05:19 AM

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Price, News, Quote & History - Yahoo! Finance Canada

05:19 AM

03:29 AM

Operating cash flow per share of BioCryst Pharmaceuticals, Inc. – DUS:BO1 - TradingView

03:29 AM

12:46 PM

BioCryst Pharmaceuticals, Inc. (BCRX) stock price, news, quote and history - Yahoo Finance Singapore

12:46 PM

Apr 05, 2026

BioCryst stock jumps after hours on big pharma suitor buzz — retail sentiment hits 2026 peak - MSN

Apr 05, 2026

Apr 05, 2026

How The BioCryst Pharmaceuticals (BCRX) Narrative Is Shifting With Astria Deal And FY26 Targets - Yahoo Finance

Apr 05, 2026

Apr 04, 2026

BCRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 04, 2026

Apr 04, 2026

BioCryst (BCRX) soars 13% on acquisition buzz - MSN

Apr 04, 2026

Apr 03, 2026

BioCryst Pharmaceuticals Inc (BO1.SG) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore

Apr 03, 2026

Apr 03, 2026

Technical Reactions to BCRX Trends in Macro Strategies - news.stocktradersdaily.com

Apr 03, 2026

Apr 03, 2026

12 new BioCryst hires receive stock awards tied to 157,300 shares - Stock Titan

Apr 03, 2026

Apr 02, 2026

Investors Purchase High Volume of Call Options on BioCryst Pharmaceuticals (NASDAQ:BCRX) - MarketBeat

Apr 02, 2026

Apr 02, 2026

BCRX Forecast, Price Target & Analyst Ratings | BIOCRYST PHARMACEUTICALS INC (NASDAQ:BCRX) - ChartMill

Apr 02, 2026

Apr 01, 2026

BioCryst Pharmaceuticals Stock: Navigating Biotech Innovation and Investor Opportunities in Rare Dis - AD HOC NEWS

Apr 01, 2026

Mar 31, 2026

Assenagon Asset Management S.A. Lowers Holdings in BioCryst Pharmaceuticals, Inc. $BCRX - marketbeat.com

Mar 31, 2026

Mar 30, 2026

BioCryst Pharmaceuticals, Inc. $BCRX Shares Sold by JPMorgan Chase & Co. - MarketBeat

Mar 30, 2026

Mar 30, 2026

Rate Cut: Is BioCryst Pharmaceuticals Inc subject to activist investor interest2026 Momentum & Reliable Breakout Stock Forecasts - baoquankhu1.vn

Mar 30, 2026

Mar 28, 2026

BioCryst 2025 slides: path to $1B revenue, Navenibart expands portfolio - Investing.com Canada

Mar 28, 2026

Mar 27, 2026

Earnings call transcript: BioCryst Q4 2025 shows strong growth, stock dips - Investing.com Australia

Mar 27, 2026

Mar 27, 2026

Earnings call transcript: BioCryst Q4 2025 shows strong growth, stock dips By Investing.com - Investing.com South Africa

Mar 27, 2026

Mar 27, 2026

BioCryst targets $1B ORLADEYO peak and $700M cash by 2027 as leadership shifts and pipeline advances - MSN

Mar 27, 2026

Mar 27, 2026

Why Did BCRX Stock Surge Over 10% In After-Hours Trading Today? - Stocktwits

Mar 27, 2026

Mar 26, 2026

Vanguard amends Schedule 13G — BioCryst (BCRX) ownership shown as 0 - Stock Titan

Mar 26, 2026

Mar 26, 2026

Does BioCryst Pharmaceuticals (BCRX) Still Offer Value After Recent Share Price Strength? - Sahm

Mar 26, 2026

Mar 25, 2026

BioCryst Shares Remain Undervalued, RBC Says - marketscreener.com

Mar 25, 2026

Mar 25, 2026

RBC Capital Maintains BioCryst Pharmaceuticals(BCRX.US) With Buy Rating, Maintains Target Price $13 - Moomoo

Mar 25, 2026

Mar 25, 2026

RBC Capital reiterates BioCryst stock rating on takeout potential - Investing.com

Mar 25, 2026

Mar 25, 2026

RBC Capital reiterates BioCryst stock rating on takeout potential By Investing.com - Investing.com Canada

Mar 25, 2026

Mar 25, 2026

BioCryst appoints Charlie Gayer to succeed Jon Stonehouse as CEO - MSN

Mar 25, 2026

Mar 24, 2026

Insider Sell: Theresa Heggie Sells 49,933 Shares of BioCryst Pha - GuruFocus

Mar 24, 2026

Mar 24, 2026

Major Insider Move at BioCryst Shakes Up Investor Buzz - TipRanks

Mar 24, 2026

Mar 24, 2026

Buybacks Report: Is BioCryst Pharmaceuticals Inc benefiting from interest rate changes2026 Snapshot & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Mar 24, 2026

Mar 24, 2026

Hereditary Angioedema Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Barchart.com

Mar 24, 2026

Mar 24, 2026

Biocryst Pharmaceuticals Insider Sold Shares Worth $504,823, According to a Recent SEC Filing - MarketScreener

Mar 24, 2026

Mar 24, 2026

Option exercise and sale by BioCryst (BCRX) director Theresa Heggie - Stock Titan

Mar 24, 2026

Mar 24, 2026

BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap UpWhat's Next? - MarketBeat

Mar 24, 2026

Mar 24, 2026

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Mar 24, 2026